A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Coherus Oncology, Inc.
Vividion Therapeutics, Inc.
Harbinger Health
BioNTech SE
St. Jude Children's Research Hospital
Assistance Publique - Hôpitaux de Paris
Jules Bordet Institute
Centre Oscar Lambret
Centre Oscar Lambret
AbbVie
Washington University School of Medicine
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
NeoImmuneTech
Alterome Therapeutics, Inc.
Mayo Clinic
Johns Hopkins University
Eisai Inc.
BioNTech SE
Aarhus University Hospital
UMC Utrecht
University Hospital, Clermont-Ferrand
Institut du Cancer de Montpellier - Val d'Aurelle
Psyence Australia Pty Ltd
Cartography Biosciences
Boston Scientific Corporation
Coherus Oncology, Inc.
ViroMissile, Inc.
Eisai Inc.
Replimune Inc.
Amgen
Eisai Inc.
The First Hospital of Jilin University
Hospices Civils de Lyon
Cancer Research UK
Sichuan Enray Pharmaceutical Sciences Company
Lokon Pharma AB
Pfizer
Astellas Pharma Inc
Duke University
AstraZeneca
A2 Biotherapeutics Inc.
University of Florida
Boston Scientific Corporation
Tizona Therapeutics, Inc
SEED Therapeutics, Inc.
Essen Biotech
Essen Biotech